Experts' Perspectives: Top Stories in Cardiology for 2024
HCPLive
DECEMBER 23, 2024
To celebrate the close of 2024, we surveyed top cardiologist on what they view as the biggest storyline in their field from the past year.
Sat.Dec 21, 2024 - Fri.Dec 27, 2024
124 
Five Tests To Assess Your Heart Health In The New Year.
Dr. Paddy Barrett
DECEMBER 27, 2024
I am a little odd. At least, according to my wife, anyway. I love Mondays and January. Everyone else seems to dislike these calendar milestones, but for me, they represent a fresh start and the opportunity to reassess the work that needs to be done. As we approach the end of the year and prepare to set out into the next one, the most common New Year resolutions are often health-related.
Less Sleep During and After Pregnancy May Spell Future Heart Troubles
Med Page Today
DECEMBER 26, 2024
(MedPage Today) -- Persistently short sleep duration during and after pregnancy was tied to a greater risk for adverse cardiometabolic outcomes, a secondary analysis of cohort study data showed. Women who said they slept fewer than 7 hours a night.
Reprogramming cells for heart repair: New method transforms ordinary fibroblasts into mature cardiomyocytes
Medical Xpress - Cardiology
DECEMBER 24, 2024
Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since the heart has minimal ability to regenerate itself. But what if we could reprogram the body's own cells to restore damaged tissue?
Use of Ibuprofen, Other NSAIDs During Pregnancy Could Increase Risk of Childhood CKD
HCPLive
DECEMBER 23, 2024
Gestational exposure to certain NSAIDs during different trimesters of pregnancy was associated with an increased risk of childhood CKD.
Breaking new ground in treatment of coronary calcium
Heart BMJ
DECEMBER 23, 2024
Extracorporeal shock wave lithotripsy (ESWL) is standard of care for the treatment of renal calculi. Fracturing large renal calculi using acoustic energy allows them to be safely passed as smaller fragments therefore avoiding surgical treatment. The adaption of ESWL to the vascular space, termed intravascular lithotripsy (IVL), could be said to have a similar goal and has sparked renewed interest in the percutaneous treatment of calcified coronary artery disease (CCAD).
Medicare Will Cover Blood Tests to Monitor for Transplant Rejection, for Now
Med Page Today
DECEMBER 27, 2024
(MedPage Today) -- In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a blood test used to monitor for transplant rejection.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss
HCPLive
DECEMBER 22, 2024
In this episode, hosts discuss the efficacy of MariTide for obesity, a head-to-head comparison of semaglutide vs. tirzepatide, and concerns about GLP-1 agonist compounding.
Predictors of Early Death in Patients With Wild‐Type Transthyretin Cardiac Amyloidosis
Journal of the American Heart Association
DECEMBER 24, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundFor the time being, tafamidis is the only approved treatment for wildtype transthyretin cardiac amyloidosis. However, benefits on allcause death only emerge after 18 months. The current available staging systems are unable to specifically discriminate patients at high risk of death within 18 months from diagnosis, and the selection of patients who are expected to benefit from tafamidis is left to the clinical judgment of treati
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
Med Page Today
DECEMBER 23, 2024
(MedPage Today) -- The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to diet and exercise. This is.
New laser technology improves stent effectiveness in vascular treatments
Medical Xpress - Cardiology
DECEMBER 27, 2024
A Korea Institute of Science and Technology (KIST) research team has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while inhibiting smooth muscle cell dedifferentiation in blood vessels.
Guselkumab 100 mg Every 8 Weeks Consistently Improves Joint, Skin Through Week 24
HCPLive
DECEMBER 21, 2024
The COSMOS trial showed guselkumab every 8 weeks improved PsA outcomes through week 48, including in patients with inadequate responses to TNF inhibitors.
Geographic Disparities in Availability of Hospital-Based Cardiac Services Across the United States
Circulation
DECEMBER 25, 2024
Circulation, Volume 151, Issue 1 , Page 123-124, January 7, 2025.
New-Onset Epilepsy, Migraine Tied to Hypertensive Disorders of Pregnancy
Med Page Today
DECEMBER 23, 2024
(MedPage Today) -- Hypertensive disorders of pregnancy -- gestational hypertension, preeclampsia, or eclampsia -- were tied to an increased risk of new-onset neurologic disorders years after giving birth, Swedish registry data showed. Women.
Wearable tech takes on heart health: Exploring advancements in cardiovascular disease monitoring
Medical Xpress - Cardiology
DECEMBER 24, 2024
Cardiovascular diseases remain a global health crisis, spurring an urgent demand for innovative diagnostic tools that enable early detection and effective treatment. Wearable heart sound devices represent a significant shift in cardiac care, offering continuous, non-invasive monitoring with the potential to revolutionize the prevention, diagnosis, and treatment of cardiovascular conditions.
Sleep Medicine Year in Review: 2024
HCPLive
DECEMBER 25, 2024
From FDA approvals to updated guidelines, 2024 brought transformative advancements in sleep medicine, offering new hope for managing complex sleep disorders.
Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension
Hypertension Journal
DECEMBER 27, 2024
Hypertension, Ahead of Print. BACKGROUND:The cholinesterase inhibitor pyridostigmine is used to treat orthostatic hypotension by facilitating cholinergic neurotransmission in autonomic ganglia, thereby harnessing residual sympathetic tone to increase blood pressure (BP) preferentially in the upright posture. We hypothesized that less severe autonomic impairment was associated with greater pressor responses to pyridostigmine.METHODS:To identify predictors of pressor response, linear regression an
Bill Clinton Hospitalized; Lower Cost Ozempic? WHO Withdrawal Planned
Med Page Today
DECEMBER 24, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Former President Bill Clinton was admitted to MedStar Georgetown University Hospital in Washington, D.C. on Monday with a fever, according to his spokesperson.
Unexpected heart muscle growth found in patients with artificial hearts
Medical Xpress - Cardiology
DECEMBER 21, 2024
A research team co-led by a physician-scientist at the University of Arizona College of MedicineTucson's Sarver Heart Center found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure. The results were published in the journal Circulation.
Rising Atherogenic Index of Plasma Tied to Increased Psoriasis Risk
HCPLive
DECEMBER 23, 2024
A study indicates that dyslipidemia may be associated with a greater risk of psoriasis development.
Referral Networks, Racial Inequity, and Hospital Quality for Open Heart Surgery
Circulation: Cardiovascular Quality & Outcomes
DECEMBER 27, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Differences in the quality of hospitals where Black and White patients receive coronary artery bypass grafting (CABG) surgery have been documented. We examined the contributions of physician networks to the gap.METHODS:This was a cross-sectional study of all Medicare fee-for-service Black and White patients undergoing elective CABG during 2017 to 2019; the primary care physicians and cardiologists treating them for 12 m
Higher-Dose Anticoagulation Not a Sure Bet for Hospitalized COVID Patients
Med Page Today
DECEMBER 24, 2024
(MedPage Today) -- Trials evaluating anticoagulation in patients hospitalized for COVID-19 did not consistently favor stepping up dosing for short-term survival, according to a systematic review and prospective meta-analysis. Among 22 studies.
Rheumatoid arthritis associated with increased risk for new heart failure
Medical Xpress - Cardiology
DECEMBER 21, 2024
Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online Dec. 9 in Arthritis Care & Research.
Hyperglycemia, Obesity Relevant Risk Factors for Retinopathy in Type 1 Diabetes
HCPLive
DECEMBER 23, 2024
Glycemic control continues to be a major risk factor for diabetic retinopathy, while overweight, obesity, and hypertension are growing in prevalence.
Revisiting this craving for post-holiday solitude
Heart Sisters
DECEMBER 22, 2024
Have you had a bit too much people-time this holiday season? The late Dr. Ester Buchholz explained that meaningful alone-time "actually allows us to connect to others in a far richer way.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
Med Page Today
DECEMBER 21, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
More blood transfusions linked to lower 6-month mortality in heart-attack patients with anemia
Medical Xpress - Cardiology
DECEMBER 23, 2024
Giving more blood to anemic patients after a heart attack may save lives, according to a Rutgers Healthled study. The study, published in NEJM Evidence, affirms research conducted in 2023 that suggested mortality rate or recurrent heart attacks were more frequent in anemic patients who received less blood.
Study Highlights Comorbidities Before, After Bullous Pemphigoid Diagnosis
HCPLive
DECEMBER 21, 2024
In this casecontrol study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.
Atherothrombotic Outcomes After Sodium‐Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: A Territory‐Wide Retrospective Cohort Study
Journal of the American Heart Association
DECEMBER 24, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundThis study compared the risks of atherothrombotic major adverse cardiovascular events in patients with type 2 diabetes taking SGLT2 (sodiumglucose cotransporter 2) inhibitors to those taking DPP4 (dipeptidyl peptidase4) inhibitors.Methods and ResultsAll adult patients (18 years of age) with type 2 diabetes and newly prescribed with SGLT2 inhibitors or DPP4 inhibitors across all public hospitals in Hong Kong between January 2015
ART & Heart Safety; Eosinophil Counts Post MI; Antibiotics Fall Short After TAVR
Med Page Today
DECEMBER 24, 2024
(MedPage Today) -- Use of assisted reproductive technology (ART) was not significantly associated with an increased long-term risk of cardiovascular diseases in women, according to a meta-analysis. (European Heart Journal) A randomized trial in.
New MRI technique identifies heart disease risk from fat composition
Medical Xpress - Cardiology
DECEMBER 23, 2024
Everyone knows the health risks of carrying too much fat around the waist and hips, but UVA Health scientists are developing a noninvasive way to assess the health risks of unseen fat around the heart.
HCPLive Year in Review: Top Podcasts & Shows for 2024
HCPLive
DECEMBER 26, 2024
From groundbreaking therapies to ethical dilemmas, HCPLives top podcasts of 2024 delivered expert insights and human stories across medicine.
Mechanical Circulatory Support for Massive Pulmonary Embolism
Journal of the American Heart Association
DECEMBER 24, 2024
Journal of the American Heart Association, Ahead of Print. Up to 50% of patients with pulmonary embolism (PE) experience hemodynamic instability and approximately 70% of patients who die of PE experience an accelerated cascade of symptoms within the first hours of onset of symptoms, thus necessitating rapid evaluation and intervention. Venoarterial extracorporeal membrane oxygenation and other ventricular assist devices, depending on the hemodynamic derangements present, may be used to stabilize
Top ACC Content in 2024
American College of Cardiology
DECEMBER 23, 2024
What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world!
Coronary artery disease common in patients with cirrhosis
Medical Xpress - Cardiology
DECEMBER 22, 2024
Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 in the Journal of Clinical and Translational Hepatology.
The Rise, Fall (and Future?) of MDMA-Assisted Therapy
HCPLive
DECEMBER 23, 2024
MDMA-assisted therapy, a source of hope for many, went on a tumultuous journey in 2024, going from historichype to setbacks.
Strategies and Criteria for the Diagnosis and Management of Myocarditis
NEJM Journal Watch - Cardiology
DECEMBER 25, 2024
The ACC proposes a new 5-step process for evaluation and management and defines a 4-stage spectrum of myocarditis.
Let's personalize your content